Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Medtronic: Commences overseas roll-out of the beStent 15mm balloon-expandable stent in Europe and "other world markets." The device utilizes a "serpentine mesh design" that provides "increased strength, scaffolding, and flexibility for the treatment of coronary lesions," Medtronic claims. The beStent also features radiopaque markers at the stent's ends to help physicians position the stent under fluoroscopy. The beStent launch follows the limited overseas release of the firm's Wiktor-i next generation Wiktor stent in October. The Wiktor-i balloon expandable stent for coronary angioplasty is available in 10-, 20- and 30-mm lengths to support lesion areas that may have required two or more 15 mm stents...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel